OVB — Ovoca Bio Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- £1.02m
- -£1.15m
Annual balance sheet for Ovoca Bio, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 10.7 | 6.59 | 3.7 | 3.34 | 2.51 |
Net Total Receivables | 0.043 | 0.334 | 1.23 | 0.121 | 0.058 |
Total Inventory | |||||
Total Current Assets | 11.1 | 7.02 | 4.98 | 3.46 | 2.56 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.007 | 0.018 | 0 | 0 | 0 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 19 | 14.8 | 9.4 | 3.47 | 2.65 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.449 | 1.34 | 1.56 | 0.528 | 0.368 |
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.486 | 1.34 | 1.77 | 0.967 | 0.594 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 18.6 | 13.4 | 7.63 | 2.5 | 2.06 |
Total Liabilities & Shareholders' Equity | 19 | 14.8 | 9.4 | 3.47 | 2.65 |
Total Common Shares Outstanding |